The hottest medical device market will reach 300bi

The medical device market will reach 300 billion in 2015, driven by the middle and low-end

Chen Zhu, Minister of health, recently released the "healthy China 2020" Strategic Research Report on the "2012 China Health Forum", pointing out that by 2020, the total health expenditure will account for 6.5% to 7% of China's GDP. Some analysts believe that this means that China's health expenditure will reach 6.5 trillion -7 trillion yuan in 2020, and the pharmaceutical and medical industry will suffer long-term benefits again. Chen Zhu, Minister of health, recently released the Research Report on healthy China 2020 strategy at the 2012 China Health Forum, pointing out that by 2020, the total health expenditure will account for 6.5% to 7% of China's GDP. Some analysts believe that, This means 2 "We are shifting the focus of our development from spandex to aramid and other new materials. In 2020, China's health expenditure will reach 6.5 trillion-7 trillion yuan, and the pharmaceutical and medical industry will benefit in the long term. With the acceleration of urbanization and aging in China, the entire pharmaceutical and medical industry, including medical services, drugs, medical devices and so on, will benefit in the long term. Compared with drugs, the growth of medical devices and medical services has started late, Growth is more prominent. The growth expectation of medical devices is high, and the compound growth rate of the industry from 2000 to 2010 is as high as more than 20%. It is estimated that by 2015, China's medical device market is expected to reach 300billion yuan

grassroots institutions are the main consumer market of medium and low-end medical equipment. Some basic configurations, such as stethoscope, sphygmomanometer, thermometer, blood glucose meter, disinfection and sterilization equipment, are in great demand. In addition to their high efficiency, equipment such as high-frequency X-ray machine, B-ultrasound machine, electrocardiogram machine and biochemical analyzer are required to be equipped except for township health centers, and the market capacity is large

people in the medical device industry expect that according to the government's gradual reform and investment plan for grassroots medical institutions since 2006, by the end of 2013, the transformation of county-level hospitals, county traditional Chinese medicine hospitals, County Maternal and child health centers, community health centers, and township health centers funded by the government will be completed, and the annual government investment is expected to reach 16billion yuan, which will directly drive the growth of the medium and low-end medical equipment industry by more than 10%

facing the huge investment of more than 720000 grass-roots medical institutions and the government in grass-roots institutions of about 37 billion yuan, all kinds of domestic medical device enterprises are optimistic about the grass-roots medical device market. So far, the lonely market at the grass-roots level has triggered three powerful forces to enter China's grass-roots market and launch a fierce competition

the first camp is the domestic excellent enterprises that originally focused on the medium and low-end market. Due to the natural advantages of Chinese medical device enterprises in the medium and low-end market, such as the price advantage brought by low production costs, the relative preference of national policies, the advantage of mastering localization channels, and so on, more and more domestic enterprises have increased their efforts to develop the grass-roots market, such as Yuyue medical, Xinhua medical, China Resources Wandong Lepu medical and other enterprises have launched plans to occupy the grass-roots market

the second camp is the domestic leading enterprises that originally focused on the high-end and export markets, such as Mindray medical, which has a share in the middle and low-end markets such as portable monitors and ultrasounds

the third camp is foreign leading enterprises focusing on the high-end market, such as GE, Siemens, Philips? Launched a strategic plan, or cooperate with local enterprises to produce more products to meet the needs of low-end medical devices in the grass-roots market

the primary medical device market is still the main theme of development, and local enterprises have great opportunities in this industry background. In the next two years, the market share of medium and low-end medical devices will maintain rapid growth, of which the compound growth rate of the household market is 30% - 35%, and the growth rate of medium and low-end medical devices is 25% - 30%

research and Analysis on the market development situation of domestic medical devices in 2012

the share of domestic medical devices in the domestic market is less than 1/3, and 30% of medical device enterprises lack independent production capacity. Where will domestic medical equipment go

both from the medical device industry and from the feedback information of the health device industry, there are problems of small enterprise scale and lack of competitiveness of products. At the same time, there is a lack of regulations to regulate the healthy development of the industry. Industry insiders believe that the government should strictly regulate, crack down on fake and shoddy products, and introduce various policies to encourage innovation, so that national brands can move in the right direction in the competition with foreign brands

domestic brands are frustrated in the high-end medical device Market

by the end of 2010, the number of medical device related manufacturing enterprises in China has exceeded 14000, of which 99% are private enterprises, but at present, the share of domestic medical devices in the domestic market is less than 1/3

only in terms of the medical device industry, there are about 3000 medical device manufacturers in China at present, but most of them are small-scale and have limited market dominance. According to the latest survey of the health equipment industry conducted by the China Health Care Association, 778 of the 2152 enterprises participating in the survey can collect business data, of which 32 have an annual turnover of more than 100million yuan, accounting for only 3.98%, and 270 have a turnover of 10 million yuan to 100 million yuan, accounting for 34.7%

Guangdong ZIWEIXING Industrial Co., Ltd. is the largest health care and medical device enterprise in China, with an annual sales volume of 254million yuan. In contrast, foreign health care devices occupy the high-end market in China. According to statistics, at present, foreign health care products enterprises sell more than 500 kinds of health care devices in China, and their annual sales have increased at an average rate of 12% in the past five years. Among the 100 domestic consumers who bought health care devices, about 15 bought foreign brands

Jiang Feng, President of China Medical Device Industry Association and chairman of China medical device industry technology innovation strategic alliance, believes that there are only a few leading enterprises in the medical device industry, such as Mindray and Weigao, and innovative enterprises like Ruide are not large. There are two main reasons why medical device enterprises are not big enough. On the one hand, domestic enterprises often have short-term behavior in research and development, always want to imitate the products that sell well at present, and are used to innovating in imitation. But if you want to occupy a place in the world, you must have original technology, whether purchased or developed. On the other hand, there are obstacles in the R & D and industrial convergence of colleges and universities. Some data show that at present, the conversion rate of patents in biological engineering in China's scientific research institutions may be only about 6%

expect policy support

however, in China, there is a vast market for both medical devices and health care devices. Compared with the international health device market, China's health device industry still has huge development space. In developed countries, the output value related to health industry accounts for 8% - 15% of GDP, while China accounts for less than 2%; In terms of the share of medical devices in the global pharmaceutical market, the United States, Japan and Europe account for 72%, and China's national industrial products account for only 3%

the demand gap is large, and the medical device stocks are optimistic

there is no event stimulus, and there is no direct policy benefit. However, the medical device stocks have quietly improved recently, and Shangrong medical, Xinhua medical, and Hejia shares have accumulated considerable gains. In particular, Hejia shares have been operating in the upward channel since the beginning of the year, and Xinhua medical has also shown a tenacious upward trend since May

medical devices still remain strong, and the market logic is still the huge medical market space, the general trend of aging society, etc. these anti cyclical factors are used by funds, thus becoming a weak haven. In comparison, the growth expectation of medical devices is also high, with a compound growth rate of more than 20% from 2000 to 2010. It is estimated that by 2015, China's medical device market is expected to reach 300billion yuan

industry analysis points out that the current consumption ratio of medical devices and drugs in China is far from that in developed countries, the consumption ratio of medical devices and drugs is close to 1:1, and that in China is only 1:10. Therefore, it can be seen that there is still a large gap in China's medical device industry, and the future prospects are broad. With the continuous improvement of people's consumption ability and health awareness, especially the household medical market, it is more worthy of attention. At present, the valuation of this sector is at a relatively reasonable level